MAP2K7 and gastric neoplasm: In an independent set of 22 cell lines of gastric tumour origin with both RNAseq expression and selumetinib pharmacology, the MEK signature was found similarly predictive of response to selumetinib (ANOVA p < 0.00054) (Figure 1).